Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

171623

registered interest
date	18/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people were diagnosed with dementia in each year since May 2010.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	219541
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>The number of people recorded on practice disease registers is available in the Quality and Outcomes Framework (QOF), published by the Health and Social Care Information Centre. The numbers of diagnoses are not available but the numbers of people on the dementia register is shown in the table below. This is a measure of prevalence rather than incidence.</p><p> </p><p> </p><p> </p><p>Number of patients on the QOF dementia register in England</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>Number of Practices</p></td><td><p>Sum of List Sizes</p></td><td><p>Dementia Register Counts</p></td></tr><tr><td><p>31 March 2014</p></td><td><p>7,921</p></td><td><p>56,324,887</p></td><td><p>348,973</p></td></tr><tr><td><p>31 March 2013</p></td><td><p>8,020</p></td><td><p>56,012,096</p></td><td><p>318,669</p></td></tr><tr><td><p>31 March 2012</p></td><td><p>8,123</p></td><td><p>55,525,732</p></td><td><p>293,738</p></td></tr><tr><td><p>31 March 2011</p></td><td><p>8,245</p></td><td><p>55,169,643</p></td><td><p>266,697</p></td></tr><tr><td><p>31 March 2010</p></td><td><p>8,305</p></td><td><p>54,836,561</p></td><td><p>249,463</p></td></tr></tbody></table><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 05/01/2015 16:13:06 answering member 1439 label Biography information for Norman Lamb
tabling member	4243 label Biography information for Dan Jarvis

171635

registered interest
date	18/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	South West
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what identifiable expenditure his Department has spent on Cornwall and the Isles of Scilly in each year since 2007-08.
tabling member constituency	Truro and Falmouth
tabling member printed	Sarah Newton
uin	219403
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>Net operating costs for Cornwall and Isles of Scilly Primary Care Trust (PCT) for 2007-08 to 2012-13, and National Health Service Kernow for 2013-14 are as follows:</p><p> </p><p> </p><p> </p><p>NHS Kernow Clinical Commissioning Group</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£000’s</p></td></tr><tr><td><p>2013-14</p></td><td><p>688,724</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Cornwall and Isles of Scilly PCT (5QP)</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>£000’s</p></td></tr><tr><td><p>2012-13</p></td><td><p>957,991</p></td></tr><tr><td><p>2011-12</p></td><td><p>925,132</p></td></tr><tr><td><p>2010-11</p></td><td><p>905,442</p></td></tr><tr><td><p>2009-10</p></td><td><p>858,510</p></td></tr><tr><td><p>2008-09</p></td><td><p>800,153</p></td></tr><tr><td><p>2007-08</p></td><td><p>752,115</p></td></tr></tbody></table><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 05/01/2015 15:35:26 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4071 label Biography information for Sarah Newton

170932

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 30 October 2013 (WA 259), 26 November 2013 (WA 263), 3 December 2013 (WA 36), 3 December 2014 (HL3158) and 16 December 2014 (HL3461), whether they consider there to be any barriers to a universally agreed definition of genetic modification, in the light of the Chief Medical Officer’s views on the matter; if so, what are the "rather mixed and odd ways" in which others have used terms like "genetic modification," "GM" and "germline"; and how the statements by the Human Fertilisation and Embryology Authority and the Nuffield Council on Bioethics are consistent with their view that "this process is not genetic modification".
tabling member printed	Lord Alton of Liverpool
uin	HL3839
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>The Human Fertilisation and Embryology Authority refers to the proposed mitochondrial donation techniques as “germ-line modification” and the Nuffield Council on Bioethics as “germ line gene therapy”. As I stated in my Written Answer of 16 December 2014 (HL3461), we agree with this and believe it to be consistent with our view that the proposed mitochondrial donation techniques are not genetic modification.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 14:55:56 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

170933

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Abortion
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, further to the answer by Earl Howe on 16 December (HL Deb, col 103), that "noble Lords around the House will form their own conclusions on the information provided by the noble Lord, Lord Alton" concerning the relative numbers of males and females and the prevalence of gender selection abortions in China, what conclusion they draw.
tabling member printed	Lord Alton of Liverpool
uin	HL3840
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>As stated in my response to the noble Lord on 16 December (HL Deb, Col 103), I shall undertake the commitment to contact the Department for International Development.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 14:59:05 answering member 2000 label Biography information for Earl Howe
tabling member	738 label Biography information for Lord Alton of Liverpool

170937

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nurses: North East
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to address any shortage of nurses in the North East of England; and whether they have considered the implications of the possible failure to renew the contract currently held by Northumbria University for nurse and other related training.
tabling member printed	Lord Beecham
uin	HL3844
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>Health Education North East (HENE) is working closely with the nurse leaders across the region to develop a Nursing Recruitment and Retention Strategy to address the shortage of nurses. The development of the strategy was agreed by HENE’s governing body at its meeting in September 2014.</p><p> </p><p> </p><p> </p><p>HENE has a successful history of working with two high quality providers of nursing education, Northumbria and Teesside Universities, and there is no current intention to terminate either of these annual nursing contracts. Additionally, HENE has begun working with the Open University (OU) to develop future flexible routes into nursing by commissioning extra adult nurse places through the OU programme.</p><p> </p><p><strong> </strong></p><p> </p><p>Health Education England has reached agreement with Universities UK and the Council of Deans on contracts with universities, including Northumbria, for the provision of nurse and other related training.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 12:56:44 answering member 2000 label Biography information for Earl Howe
tabling member	4181 label Biography information for Lord Beecham

170942

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Priorities Advisory Group
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what discussions they have had with NHS England regarding delays in the Clinical Priorities Advisory Group's consideration of specialised treatments and the impact on people who cannot currently access treatments recommended by their clinician.
tabling member printed	Baroness Gale
uin	HL3849
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>NHS England has advised that a meeting of its Clinical Priorities Advisory Group has been delayed whilst further work is undertaken to refine the overall decision making process. NHS England remains committed however, to ensuring that a timely decision is made about a range of investment proposals that have been put forward for the 2015-16 financial year.</p><p> </p><p> </p><p> </p><p>At the November public meeting of the NHS England Board it was agreed to create a new Specialised Services Committee of the Board, and as a consequence to review the current governance arrangements covering this aspect of NHS England’s work.</p><p> </p><p> </p><p> </p><p>It was decided to undertake a public consultation on the future approach to prioritising new treatments and interventions within specialised commissioning. This was considered at the December NHS England Board meeting and it was agreed that a 90 day consultation will be carried out in early 2015.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the short postponement of the Clinical Priorities Advisory Group meeting will have no impact on the decision making timetable for commissioning NHS services from April 2015 onwards.</p><p> </p><p> </p><p> </p><p>Existing treatments will continue to be commissioned in the meantime, ensuring that support for patients is maintained.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 12:52:12 answering member 2000 label Biography information for Earl Howe
tabling member	2503 label Biography information for Baroness Gale

170943

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to ensure that people in the advanced stages of Parkinson's disease have access to a full range of treatment options.
tabling member printed	Baroness Gale
uin	HL3850
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p><em>Parkinson’s disease: Diagnosis and management in primary and secondary care</em>, published by the National Institute for Health and Care Excellence (NICE) in 2006 sets out a range of treatment options for Parkinson’s disease.</p><p> </p><p> </p><p> </p><p>Treatments for Parkinson’s disease are largely drug based. The NICE guidance states that patient preference should be taken into account, once they have been informed of the short and long-term benefits and drawbacks of the different types of drugs available. The guidance makes it clear that other supportive treatments may also be appropriate. These can include physiotherapy, occupational therapy and speech and language therapy.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 12:50:41 answering member 2000 label Biography information for Earl Howe
tabling member	2503 label Biography information for Baroness Gale

170944

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Co-careldopa
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what representations they have received about access to Duodopa for people in the advanced stages of Parkinson's disease; and what responses they have made.
tabling member printed	Baroness Gale
uin	HL3851
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>We have received a number of representations from hon. Members, noble Lords, patient groups and members of the public about access to Duodopa for the treatment of advanced Parkinson’s disease on the National Health Service.</p><p> </p><p> </p><p> </p><p>Our responses have made clear that NHS England has responsibility for commissioning adult specialist neurosciences services, including the majority of services for patients with Parkinson’s disease and have set out NHS England’s position on this issue at the time of writing.</p><p> </p> answering member printed Earl Howe question first answered 05/01/2015 12:50:15 answering member 2000 label Biography information for Earl Howe
tabling member	2503 label Biography information for Baroness Gale

170946

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Priorities Advisory Group
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to ensure that the Clinical Priorities Advisory Group operates in a transparent manner.
tabling member printed	Baroness Howells of St Davids
uin	HL3853
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>NHS England has advised that discussion at executive level has taken place. A consultation will be launched early in the new year on how NHS England carries out its considerations on the commissioning of new treatments and interventions as part of a prioritisation process. Once the proposals have been consulted on and a final decision has been published regarding the NHS England operations and decision making process to be used, the Clinical Priorities Advisory Group (CPAG) will operate under these terms.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the work of CPAG has been communicated through various public meetings and presentations. Current terms of reference are on the NHS England website. Any CPAG recommendations which are approved by the Specialised Commissioning Oversight Group are published on the NHS England website. A newsletter is also circulated to patient groups and relevant networks.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3854 question first answered 05/01/2015 12:49:46 answering member 2000 label Biography information for Earl Howe
tabling member	2486 label Biography information for Baroness Howells of St Davids

170947

registered interest
date	17/12/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Priorities Advisory Group
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how the work of the Clinical Priorities Advisory Group is communicated to the public.
tabling member printed	Baroness Howells of St Davids
uin	HL3854
answer	answer is ministerial correction date of answer 05/01/2015 answer text <p>NHS England has advised that discussion at executive level has taken place. A consultation will be launched early in the new year on how NHS England carries out its considerations on the commissioning of new treatments and interventions as part of a prioritisation process. Once the proposals have been consulted on and a final decision has been published regarding the NHS England operations and decision making process to be used, the Clinical Priorities Advisory Group (CPAG) will operate under these terms.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the work of CPAG has been communicated through various public meetings and presentations. Current terms of reference are on the NHS England website. Any CPAG recommendations which are approved by the Specialised Commissioning Oversight Group are published on the NHS England website. A newsletter is also circulated to patient groups and relevant networks.</p><p> </p> answering member printed Earl Howe grouped question UIN HL3853 question first answered 05/01/2015 12:49:46 answering member 2000 label Biography information for Earl Howe
tabling member	2486 label Biography information for Baroness Howells of St Davids